EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019

Gabriela A Willis iD, Therese Kearns, Helen J Mayfield, Sarah Sheridan, Robert Thomsen, Take Naseri, Michael C David, Daniel Engelman, Andrew C Steer, Patricia M Graves, Colleen L Lau iD

PLOS Neglected Tropical Diseases · 2023

DOI: 10.1371/journal.pntd.0011549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Gabriela A Willis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research School of Population Health, Australian National University, Canberra, Australia. Hauptthemen laut MEDLINE: Scabies, Elephantiasis, Filarial. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill and Melinda Gates Foundation, Australian National Health and Medical Research Council Fellowship, Viertel Senior Medical Research Council Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Scabies is a common skin infestation caused by the Sarcoptes scabei mite. Ivermectin, one of three drugs used in mass drug administration (MDA) for lymphatic filariasis, is also effective for treating scabies. Ivermectin-based MDA was first conducted in Samoa in August 2018, with ivermectin being offered to those aged ≥5 years. Here, we report scabies prevalence in Samoa after MDA.

Methods

We conducted household surveys 1.5–3.5 months (Survey 1) and 6–8 months (Survey 2) after the 2018 MDA in 35 primary sampling units. We conducted clinical examination for scabies-like rash and used International Alliance for the Control of Scabies classification criteria. We estimated scabies prevalence by age, gender and region. Multivariable logistic regression was used to assess factors associated with prevalence.

Results

We surveyed 2868 people (499 households) and 2796 people (544 households) aged 0–75 years in Surveys 1 and 2, respectively. Scabies prevalence increased from 2.4% (95% CI 2.1–2.7%) to 4.4% (95% CI 4.0–4.9%) between surveys. Scabies was associated with younger age (0–4 years: aOR 3.5 [2.9–4.2]; 5–15 years: aOR 1.6 [1.4–1.8] compared to ≥16 years), female gender (aOR 1.2 [95% CI 1.1–1.4]; region (aOR range from 1.4 [1.1–1.7] to 2.5 [2.1–3.1] between regions), large households (aOR 2.6 [2.0–3.4] households ≥13), and not taking MDA in 2018 (aOR 1.3 [95% CI 1.1–1.6]).

Conclusions

We found moderate prevalence of scabies in two population-representative surveys conducted within 8 months of the 2018 MDA for lymphatic filariasis. Prevalence appeared to increase between the surveys, and ongoing surveillance is recommended, particularly in young children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ScabiesElephantiasis, FilarialChildFemaleHumansChild, PreschoolIvermectinMass Drug AdministrationPrevalenceSamoa

Substanzen

Ivermectin

Autor:innen und Institutionen

  • Research School of Population Health, Australian National University, Canberra, Australia.
  • Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
  • School of Public Health, Faculty of Medicine, University of Queensland, Brisbane, Australia.
  • National Centre for Immunisation Research and Surveillance, Sydney, Australia.
  • Ministry of Health, Apia, Samoa.
  • School of Medicine and Dentistry, Griffith University, Gold Coast, Australia.

ORCID-Profile: Gabriela A Willis, Colleen L Lau

Förderung

  • Bill and Melinda Gates Foundation
  • Australian National Health and Medical Research Council Fellowship
  • Viertel Senior Medical Research Council Fellowship
  • National Health and Medical Research Council

Zitieren

APA

Willis, G. A., Kearns, T., Mayfield, H. J., Sheridan, S., Thomsen, R., Naseri, T., David, M. C., Engelman, D., Steer, A. C., Graves, P. M., & Lau, C. L. (2023). Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011549

Vancouver

Willis GA, Kearns T, Mayfield HJ, Sheridan S, Thomsen R, Naseri T, et al. Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011549

BibTeX
@article{Willis2023,
  author = {Willis, Gabriela A and Kearns, Therese and Mayfield, Helen J and Sheridan, Sarah and Thomsen, Robert and Naseri, Take and David, Michael C and Engelman, Daniel and Steer, Andrew C and Graves, Patricia M and Lau, Colleen L},
  title = {Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2023},
  doi = {10.1371/journal.pntd.0011549}
}
Kostenlos starten →